121 related articles for article (PubMed ID: 11758636)
1. Enantioselective binding of disopyramide to alpha1-acid glycoprotein and its variants.
Kishino S; Itoh S; Nakagawa T; Miyazaki K
Eur J Clin Pharmacol; 2001 Oct; 57(8):583-7. PubMed ID: 11758636
[TBL] [Abstract][Full Text] [Related]
2. Differential binding of disopyramide and warfarin enantiomers to human alpha(1)-acid glycoprotein variants.
Nakagawa T; Kishino S; Itoh S; Sugawara M; Miyazaki K
Br J Clin Pharmacol; 2003 Dec; 56(6):664-9. PubMed ID: 14616427
[TBL] [Abstract][Full Text] [Related]
3. Age- and gender-related differences in carbohydrate concentrations of alpha1-acid glycoprotein variants and the effects of glycoforms on their drug-binding capacities.
Kishino S; Nomura A; Itoh S; Nakagawa T; Takekuma Y; Sugawara M; Furukawa H; Todo S; Miyazaki K
Eur J Clin Pharmacol; 2002 Dec; 58(9):621-8. PubMed ID: 12483455
[TBL] [Abstract][Full Text] [Related]
4. Capillary electrophoretic study on pH dependence of enantioselective disopyramide binding to genetic variants of human alpha1-acid glycoprotein.
Kuroda Y; Matsumoto S; Shibukawa A; Nakagawa T
Analyst; 2003 Aug; 128(8):1023-7. PubMed ID: 12964601
[TBL] [Abstract][Full Text] [Related]
5. Role of biantennary glycans and genetic variants of human alpha1-acid glycoprotein in enantioselective binding of basic drugs as studied by high performance frontal analysis/capillary electrophoresis.
Kuroda Y; Kita Y; Shibukawa A; Nakagawa T
Pharm Res; 2001 Mar; 18(3):389-93. PubMed ID: 11442281
[TBL] [Abstract][Full Text] [Related]
6. Binding of disopyramide, methadone, dipyridamole, chlorpromazine, lignocaine and progesterone to the two main genetic variants of human alpha 1-acid glycoprotein: evidence for drug-binding differences between the variants and for the presence of two separate drug-binding sites on alpha 1-acid glycoprotein.
Hervé F; Duché JC; d'Athis P; Marché C; Barré J; Tillement JP
Pharmacogenetics; 1996 Oct; 6(5):403-15. PubMed ID: 8946472
[TBL] [Abstract][Full Text] [Related]
7. Enantioselective binding of propranolol, disopyramide, and verapamil to human alpha(1)-acid glycoprotein.
Hanada K; Ohta T; Hirai M; Arai M; Ogata H
J Pharm Sci; 2000 Jun; 89(6):751-7. PubMed ID: 10824133
[TBL] [Abstract][Full Text] [Related]
8. Lipophilicity Influences Drug Binding to α1-Acid Glycoprotein F1/S Variants But Not to the A Variant.
Hanada K
Drugs R D; 2017 Sep; 17(3):475-480. PubMed ID: 28646384
[TBL] [Abstract][Full Text] [Related]
9. Interaction of disopyramide enantiomers for sites on plasma protein.
Lima JJ
Life Sci; 1987 Dec; 41(26):2807-13. PubMed ID: 3695808
[TBL] [Abstract][Full Text] [Related]
10. Changes in the binding capacity of alpha-1-acid glycoprotein in patients with renal insufficiency.
Kishino S; Nomura A; Di ZS; Sugawara M; Iseki K; Kakinoki S; Kitabatake A; Miyazaki K
Ther Drug Monit; 1995 Oct; 17(5):449-53. PubMed ID: 8585106
[TBL] [Abstract][Full Text] [Related]
11. Population pharmacokinetics, protein binding and antiarrhythmic effects of disopyramide enantiomers in arrhythmic patients.
Aso R; Ohashi K; Katoh T; Ogata H
Int J Clin Pharmacol Res; 2001; 21(3-4):137-46. PubMed ID: 12067143
[TBL] [Abstract][Full Text] [Related]
12. A simple method for the simulation of unbound serum disopyramide concentration in patients.
Kishino S; Kohri N; Iseki K; Miyazaki K; Nomura A; Yasuda H
J Pharmacobiodyn; 1991 Sep; 14(9):493-9. PubMed ID: 1779403
[TBL] [Abstract][Full Text] [Related]
13. Single-step isolation method for six glycoforms of human alpha1-acid glycoprotein by hydroxylapatite chromatography and study of their binding capacities for disopyramide.
Kishino S; Nomura A; Saitoh M; Sugawara M; Iseki K; Kitabatake A; Miyazaki K
J Chromatogr B Biomed Sci Appl; 1997 Dec; 703(1-2):1-6. PubMed ID: 9448056
[TBL] [Abstract][Full Text] [Related]
14. Evidence for differences in the binding of drugs to the two main genetic variants of human alpha 1-acid glycoprotein.
Herve F; Gomas E; Duche JC; Tillement JP
Br J Clin Pharmacol; 1993 Sep; 36(3):241-9. PubMed ID: 9114911
[TBL] [Abstract][Full Text] [Related]
15. The genetic variant A of human alpha 1-acid glycoprotein limits the blood to brain transfer of drugs it binds.
Jolliet-Riant P; Boukef MF; Duché JC; Simon N; Tillement JP
Life Sci; 1998; 62(14):PL219-26. PubMed ID: 9570346
[TBL] [Abstract][Full Text] [Related]
16. Human pharmacokinetics and metabolism of disopyramide enantiomers.
Le Corre P; Gibassier D; Sado P; Le Verge R
Eur J Drug Metab Pharmacokinet; 1991; Spec No 3():233-7. PubMed ID: 1820885
[TBL] [Abstract][Full Text] [Related]
17. Relationship between alpha 1-acid glycoprotein and plasma binding of disopyramide and mono-N-dealkyldisopyramide.
Bredesen JE; Kierulf P
Br J Clin Pharmacol; 1984 Nov; 18(5):779-84. PubMed ID: 6508986
[TBL] [Abstract][Full Text] [Related]
18. Identification of CYP3A4 as the enzyme involved in the mono-N-dealkylation of disopyramide enantiomers in humans.
Echizen H; Tanizaki M; Tatsuno J; Chiba K; Berwick T; Tani M; Gonzalez FJ; Ishizaki T
Drug Metab Dispos; 2000 Aug; 28(8):937-44. PubMed ID: 10901704
[TBL] [Abstract][Full Text] [Related]
19. Selective plasma protein binding of antimalarial drugs to alpha1-acid glycoprotein.
Zsila F; Visy J; Mády G; Fitos I
Bioorg Med Chem; 2008 Apr; 16(7):3759-72. PubMed ID: 18289858
[TBL] [Abstract][Full Text] [Related]
20. Interspecies differences in enantioselective mono-N-dealkylation of disopyramide by human and mouse liver microsomes.
Echizen H; Mochizuki K; Tani M; Ishizaki T
J Pharmacol Exp Ther; 1994 Mar; 268(3):1518-25. PubMed ID: 8138963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
